Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 06 2020
Historique:
received: 19 09 2019
accepted: 14 05 2020
entrez: 17 6 2020
pubmed: 17 6 2020
medline: 28 8 2020
Statut: epublish

Résumé

Tumor heterogeneity is one major reason for unpredictable therapeutic outcomes, while stratifying therapeutic responses at an early time may greatly benefit the better control of cancer. Here, we developed a hybrid nanovesicle to stratify radiotherapy response by activatable inflammation magnetic resonance imaging (aiMRI) approach. The high Pearson's correlation coefficient R values are obtained from the correlations between the T

Identifiants

pubmed: 32541769
doi: 10.1038/s41467-020-16771-y
pii: 10.1038/s41467-020-16771-y
pmc: PMC7295999
doi:

Substances chimiques

Reactive Oxygen Species 0

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3032

Subventions

Organisme : Intramural NIH HHS
ID : ZIA EB000073
Pays : United States

Références

Cuccarese, M. F. et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat. Commun. 8, 14293 (2017).
pubmed: 28176769 pmcid: 5309815 doi: 10.1038/ncomms14293
Bensch, F. et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat. Med. 24, 1852–1858 (2018).
pubmed: 30478423 doi: 10.1038/s41591-018-0255-8
Chen, H., Zhang, W., Zhu, G., Xie, J. & Chen, X. Rethinking cancer nanotheranostics. Nat. Rev. Mater. 2, 17024 (2017).
pubmed: 29075517 pmcid: 5654564 doi: 10.1038/natrevmats.2017.24
Hu, C. W. et al. A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia. Nat. Biomed. Eng. 3, 889–891 (2019).
pubmed: 30988472 pmcid: 7051028 doi: 10.1038/s41551-019-0387-2
Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81 (2017).
pubmed: 29115304 doi: 10.1038/nrclinonc.2017.166
Lindsay, K. E. et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging. Nat. Biomed. Eng. 3, 371–380 (2019).
pubmed: 30936432 doi: 10.1038/s41551-019-0378-3
Rashidian, M. et al. Noninvasive imaging of immune responses. Proc. Natl Acad. Sci. USA 112, 6146–6151 (2015).
pubmed: 25902531 doi: 10.1073/pnas.1502609112
Shuhendler, A. J. et al. Molecular magnetic resonance imaging of tumor response to therapy. Sci. Rep. 5, 14759 (2015).
pubmed: 26440059 pmcid: 4594000 doi: 10.1038/srep14759
Kasoji, S. K., Rivera, J. N., Gessner, R. C., Chang, S. X. & Dayton, P. A. Early assessment of tumor response to radiation therapy using high-resolution quantitative microvascular ultrasound imaging. Theranostics 8, 156–168 (2018).
pubmed: 29290799 pmcid: 5743466 doi: 10.7150/thno.19703
Barker, H. E., Paget, J. T. E., Khan, A. A. & Harrington, K. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409–425 (2015).
pubmed: 26105538 pmcid: 4896389 doi: 10.1038/nrc3958
Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018).
pubmed: 29686425 pmcid: 29686425 doi: 10.1038/s41591-018-0014-x
Surace, L. et al. Complement Is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. Immunity 42, 767–777 (2015).
pubmed: 25888260 doi: 10.1016/j.immuni.2015.03.009
Abdelfattah, N. et al. MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma. Nat. Commun. 9, 4541 (2018).
pubmed: 30382096 pmcid: 6208371 doi: 10.1038/s41467-018-06808-8
Shin, S. H., Park, S. H., Kim, S. W., Kim, M. & Kim, D. Fluorine MR imaging monitoring of tumor inflammation after high-intensity focused ultrasound ablation. Radiology 287, 476–484 (2018).
pubmed: 29369752 doi: 10.1148/radiol.2017171603
Krause, M., Dubrovska, A., Linge, A. & Baumann, M. Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv. Drug Deliv. Rev. 109, 63–73 (2017).
pubmed: 26877102 doi: 10.1016/j.addr.2016.02.002
Ellison, D. W. et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J. Clin. Oncol. 29, 1400–1407 (2010).
pubmed: 20921458 pmcid: 3525837 doi: 10.1200/JCO.2010.30.2810
Little, R. A. et al. Mapping hypoxia in renal carcinoma with oxygen-enhanced MRI: comparison with intrinsic susceptibility MRI and pathology. Radiology 288, 739–747 (2018).
pubmed: 29869970 pmcid: 6122194 doi: 10.1148/radiol.2018171531
Jeraj, R., Bradshaw, T. & Simončič, U. Molecular imaging to plan radiotherapy and evaluate its efficacy. J. Nucl. Med. 56, 1752–1765 (2015).
pubmed: 26383148 doi: 10.2967/jnumed.114.141424
Zhang, Y. et al. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res. 23, 898–914 (2013).
pubmed: 23752925 pmcid: 3698641 doi: 10.1038/cr.2013.75
Shi, C. et al. Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration. Nano Lett. 18, 7330–7342 (2018).
pubmed: 30339753 doi: 10.1021/acs.nanolett.8b03568
Wang, J., Zhang, Y., Archibong, E., Ligler, F. S. & Gu, Z. Leveraging H
doi: 10.1002/adbi.201700084
Xu, Q., He, C., Xiao, C. & Chen, X. Reactive oxygen species (ROS) responsive polymers for biomedical applications. Macromol. Biosci. 16, 635–646 (2016).
pubmed: 26891447 doi: 10.1002/mabi.201500440
Reth, M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3, 1129 (2002).
pubmed: 12447370 doi: 10.1038/ni1202-1129
Takeshima, T. et al. Key role for neutrophils in radiation-induced antitumor immune responses: potentiation with G-CSF. Proc. Natl Acad. Sci. USA 113, 11300–11305 (2016).
pubmed: 27651484 doi: 10.1073/pnas.1613187113
Langford, T. F., Huang, B. K., Lim, J. B., Moon, S. J. & Sikes, H. D. Monitoring the action of redox-directed cancer therapeutics using a human peroxiredoxin-2-based probe. Nat. Commun. 9, 3145 (2018).
pubmed: 30087344 pmcid: 6081480 doi: 10.1038/s41467-018-05557-y
Huang, J., Li, J., Lyu, Y., Miao, Q. & Pu, K. Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury. Nat. Mater. 18, 1133–1143 (2019).
pubmed: 31133729 doi: 10.1038/s41563-019-0378-4
Ni, D. et al. Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice. Nat. Commun. 9, 5421 (2018).
pubmed: 30575745 pmcid: 6303396 doi: 10.1038/s41467-018-07890-8
Wang, H. et al. Ultrasensitive magnetic resonance imaging of systemic reactive oxygen species in vivo for early diagnosis of sepsis using activatable nanoprobes. Chem. Sci. 10, 3770–3778 (2019).
pubmed: 30996965 pmcid: 6447818 doi: 10.1039/C8SC04961K
Huang, G. et al. PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers. Nat. Biomed. Eng. 4, 314–324 (2020).
pubmed: 31235828 doi: 10.1038/s41551-019-0416-1
Zhou, Z. et al. Synchronous chemoradiation nanovesicles by X-Ray triggered cascade of drug release. Angew. Chem. Int. Ed. 57, 8463–8467 (2018).
doi: 10.1002/anie.201802351
Zhou, Z. et al. Artificial local magnetic field inhomogeneity enhances T2 relaxivity. Nat. Commun. 8, 15468 (2017).
pubmed: 28516947 pmcid: 5454366 doi: 10.1038/ncomms15468
Shin, T.-H. et al. A magnetic resonance tuning sensor for the MRI detection of biological targets. Nat. Protoc. 13, 2664–2684 (2018).
pubmed: 30349049 doi: 10.1038/s41596-018-0057-y
Choi, J.-S. et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets. Nat. Mater. 16, 537 (2017).
pubmed: 28166216 doi: 10.1038/nmat4846
Grinstead, R. R. The oxidation of ascorbic acid by hydrogen peroxide. Catalysis by ethylenediaminetetraacetato-Iron(III). J. Am. Chem. Soc. 82, 3464–3471 (1960).
doi: 10.1021/ja01498a057
Allen, B. L., Johnson, J. D. & Walker, J. P. Encapsulation and enzyme-mediated release of molecular cargo in polysulfide nanoparticles. ACS Nano 5, 5263–5272 (2011).
pubmed: 21595444 doi: 10.1021/nn201477y
Matsuoka, Y. et al. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma. Br. J. Cancer 115, 1234 (2016).
pubmed: 27736845 pmcid: 5104896 doi: 10.1038/bjc.2016.327
Formenti, S. C. & Demaria, S. Systemic effects of local radiotherapy. Lancet Oncol. 10, 718–726 (2009).
pubmed: 19573801 pmcid: 2782943 doi: 10.1016/S1470-2045(09)70082-8
Ostrand-Rosenberg, S., Horn, L. A. & Ciavattone, N. G. Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: novel strategies for preventing the tumor-protective effects of radiotherapy. Front. Oncol. 9, 215–215 (2019).
pubmed: 31001479 pmcid: 6454107 doi: 10.3389/fonc.2019.00215
Ostrand-Rosenberg, S. & Fenselau, C. Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. J. Immunol. 200, 422–431 (2018).
pubmed: 29311384 pmcid: 5765878 doi: 10.4049/jimmunol.1701019
Multhoff, G. & Radons, J. Radiation, inflammation, and immune responses in cancer. Front. Oncol. 2, 1–18 (2012).
Eruslanov, E. B. et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Investig. 124, 5466–5480 (2014).
pubmed: 25384214 doi: 10.1172/JCI77053
Powell, D. R. & Huttenlocher, A. Neutrophils in the tumor microenvironment. Trends Immunol. 37, 41–52 (2016).
pubmed: 26700397 doi: 10.1016/j.it.2015.11.008
Wculek, S. K. & Malanchi, I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528, 413 (2015).
pubmed: 26649828 pmcid: 4700594 doi: 10.1038/nature16140
Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566, 553–557 (2019).
pubmed: 30728496 doi: 10.1038/s41586-019-0915-y
Kagan, V. E. et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 5, 354 (2010).
pubmed: 20364135 pmcid: 6714564 doi: 10.1038/nnano.2010.44
Mi, P. et al. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy. Nat. Nanotechnol. 11, 724 (2016).
pubmed: 27183055 doi: 10.1038/nnano.2016.72
Werner, E. J., Datta, A., Jocher, C. J. & Raymond, K. N. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew. Chem. Int. Ed. 47, 8568–8580 (2008).
doi: 10.1002/anie.200800212
Ananta, J. S. et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat. Nanotechnol. 5, 815 (2010).
pubmed: 20972435 pmcid: 2974055 doi: 10.1038/nnano.2010.203
Munasinghe, J. P. et al. Arterial spin labeling demonstrates that focal amygdalar glutamatergic agonist infusion leads to rapid diffuse cerebral activation. Acta Neurol. Scand. 121, 209–216 (2010).
pubmed: 19951270 doi: 10.1111/j.1600-0404.2009.01188.x

Auteurs

Zijian Zhou (Z)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Hongzhang Deng (H)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, 350116, Fujian, China.

Weijing Yang (W)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Zhantong Wang (Z)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Lisen Lin (L)

MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, 350116, Fujian, China.

Jeeva Munasinghe (J)

Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, USA.

Orit Jacobson (O)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Yijing Liu (Y)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Longguang Tang (L)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Qianqian Ni (Q)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Fei Kang (F)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Yuan Liu (Y)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Gang Niu (G)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

Ruiliang Bai (R)

Interdisciplinary Institute of Neuroscience and Technology, School of Medicine, Zhejiang University, Hangzhou, 310029, China.

Chunqi Qian (C)

Department of Radiology, Michigan State University, East Lansing, MI, 48824, USA.

Jibin Song (J)

MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, 350116, Fujian, China. jibinsong@fzu.edu.cn.

Xiaoyuan Chen (X)

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA. shawn.chen@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH